BiotechTube
Home/C4X Discovery/David Lawrence
DL

David Lawrence

Non-Executive Chairman

C4X Discovery

Therapeutic Areas

Immuno-Inflammatory Diseases

C4X Discovery Pipeline

DrugIndicationPhase
α4β7 integrin inhibitor programmeImmuno-inflammatory diseasesPre-clinical
Partnered programme with SanofiImmuno-inflammatory disease (undisclosed)Discovery/Pre-clinical
Partnered programme with AstraZenecaInflammatory disease (undisclosed)Discovery/Pre-clinical

Leadership Team at C4X Discovery

DE
Dr. Emma Blaney
CEO
DN
Dr. Nick Ray
Chief Scientific Officer
View full C4X Discovery profile